Jiangsu Kangbeide Pharmaceutical Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2008

Location

Nanjing Jiangsu China

Primary Industry

Pharmaceuticals

About

Established in 2008 and based in Nanjing, China, Jiangsu Kangbeide Pharmaceutical Co., Ltd. operates as pharmaceutical company dedicated to providing transdermal patches and topical gel patches. It acquired 7 patents and 19 registered trademarks. In June 2015, Jiangsu Kangbeide Pharmaceutical Co., Ltd. closed series A funding from new investors Hairong Capital, Ruomu Capital, Think Investment Management, Zhejiang Aoyin Asset Management and individual investors. In August 2016, Jiangsu Kangbeide Pharmaceutical Co., Ltd. listed on the New Third Board (NEEQ). The company mainly provides transdermal patches and gel ointments The transdermal patches include 11 products, different transdermal patches are suitable for different conditions such as overactive bladder, Parkinson's disease, depression, and asthma. The gel ointments include antipyretic patch, biphenylacetic acid gel ointment, and lidocaine gel ointment. The biphenylacetic acid gel ointment is suitable for degenerative joint disease, tendon and facial low back pain, and shoulder polyarthritis. The lidocaine gel ointment is suitable for postherpetic neuralgia.

Current Investors

Hairong Capital, Think Investment Management, Ruomu Capital

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.kbdpharm.com

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.